심장성 쇼크

키워드

참고문헌 (53)

1. Mtaweh H, "Advances in monitoring and management of shock", Pediatr Clin North Am, 60, pp.641~654 (2013)
2. Brissaud O, "Experts’ recommendations for the management of cardiogenic shock in children", Ann Intensive Care, 6, pp.14~ (2016)
3. Kaushik A, "A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection", Pediatr Infect Dis J, 39, pp.e340~e346 (2020)
4. Sperotto F, "Cardiac manifestations in SARSCoV-2-associated multisystem inflammatory syndrome in children : a comprehensive review and proposed clinical approach", Eur J Pediatr, 15, pp.1~16 (2020)
5. Turner DA, "Nelson textbook of pediatrics", pp.572~ (2020), Elsevier Health Sciences
6. Black RE, "Where and why are 10 million children dying every year?", Lancet, 361, pp.2226~2234 (2003)
7. Fisher JD, "Clinical spectrum of shock in the pediatric emergency department", Pediatr Emerg Care, 26, pp.622~625 (2010)
8. Singh D, "A clinical profile of shock in children in Punjab, India", Indian Pediatr, 43, pp.619~623 (2006)
9. Rossano JW, "Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States : a population-based study", J Card Fail, 18, pp.459~470 (2012)
10. Webster G, "Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations : a retrospective, cross-sectional study", BMC Cardiovasc Disord, 6, pp.23~ (2006)
11. Whittaker E, "Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2", JAMA, 324, pp.259~269 (2020)
12. Jiang L, "COVID-19 and multisystem inflammatory syndrome in children and adolescents", Lancet Infect Dis, 20, pp.e276~e288 (2020)
13. Verdoni L, "An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic : an observational cohort study", Lancet, 395, pp.1771~1778 (2020)
14. Barber AE, "Cell damage after shock", New Horiz, 4, pp.161~167 (1996)
15. Cannon JW, "Hemorrhagic shock", N Engl J Med, 378, pp.1852~1853 (2018)
16. Angus DC, "Severe sepsis and septic shock", N Engl J Med, 369, pp.2063~ (2013)
17. Hinshaw LB, "Sepsis", septic shock : participation of the microcirculation : an abbreviated review, 1996, pp.24, 1072~1078
18. Tuchschmidt JA, "Predictors of outcome from critical illness. Shock and cardiopulmonary resuscitation", Crit Care Clin, 10, pp.179~195 (1994)
19. Kantor PF, "Presentation, diagnosis, and medical management of heart failure in children : Canadian Cardiovascular Society guidelines", Can J Cardiol, 29, pp.1535~1552 (2013)
20. Mendelson J, "Emergency department management of pediatric shock", Emerg Med Clin North Am, 36, pp.427~440 (2018)
21. Nohria A, "Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure", J Am Coll Cardiol, 41, pp.1797~1804 (2003)
22. Jones TL, "Cardiogenic shock : evolving definitions and future directions in management", Open Heart, 6, pp.e000960~ (2019)
23. Overgaard CB, "Inotropes and vasopressors : review of physiology and clinical use in cardiovascular disease", Circulation, 118, pp.1047~1056 (2008)
24. Rossano JW, "Heart failure in children : etiology and treatment", J Pediatr, 165, pp.228~233 (2014)
25. Rossano JW, "Nelson textbook of pediatrics", pp.2476~ (2020), Elsevier Health Sciences
26. Biomarkers Definitions Working G, "Biomarkers and surrogate endpoints: preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)
27. Dellinger RP, "Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock : 2008", Intensive Care Med, 34, pp.17~60 (2008)
28. Hatherill M, "Early hyperlactataemia in critically ill children", Intensive Care Med, 26, pp.314~318 (2000)
29. Babuin L, "Troponin : the biomarker of choice for the detection of cardiac injury", CMAJ, 173, pp.1191~1202 (2005)
30. Tervonen V, "A novel cardiac hormone related to A-, Band C-type natriuretic peptides", Endocrinology, 139, pp.4021~4025 (1998)
31. Kantor PF, "Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: summary from the second International Conference on Pediatric Cardiomyopathy", Prog Pediatr Cardiol, 32, pp.11~14 (2011)
32. Rossano JW, "Update on pharmacological heart failure therapies in children: do adult medications work in children and if not, why not?", Circulation, 129, pp.607~612 (2014)
33. O’Connor MJ, "Ventricular assist devices in children", Curr Opin Cardiol, 29, pp.113~121 (2014)
34. Burkhoff D, "Hemodynamics of mechanical circulatory support", J Am Coll Cardiol, 66, pp.2663~2674 (2015)
35. Stevenson LW, "INTERMACS profiles of advanced heart failure : the current picture", J Heart Lung Transplant, 28, pp.535~541 (2009)
36. Teele SA, "The association of carotid artery cannulation and neurologic injury in pediatric patients supported with venoarterial extracorporeal membrane oxygenation", Pediatr Crit Care Med, 15, pp.355~361 (2014)
37. Gander JW, "Limb ischemia after common femoral artery cannulation for venoarterial extracorporeal membrane oxygenation : an unresolved problem", J Pediatr Surg, 45, pp.2136~2140 (2010)
38. Hacking DF, "Elective decompression of the left ventricle in pediatric patients may reduce the duration of venoarterial extracorporeal membrane oxygenation", Artif Organs, 39, pp.319~326 (2015)
39. Jatene MB, "Pediatric heart transplantation in refractory cardiogenic shock : a critical analysis of feasibility, applicability and results", Arq Bras Cardiol, 90, pp.329~333 (2008)
40. Miera O, "First experiences with the HeartWare ventricular assist system in children", Ann Thorac Surg, 91, pp.1256~1260 (2011)
41. Blume ED, "Outcomes of children implanted with ventricular assist devices in the United States : first analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support(PediMACS)", J Heart Lung Transplant, 35, pp.578~584 (2016)
42. 신정훈, "The First Pediatric Heart Transplantation Bridged by a Durable Left Ventricular Assist Device in Korea", Journal of Chest Surgery, 53(2), pp.79~81 (2020), 대한심장혈관흉부외과학회[DOI]
43. Fulchand S, "Covid-19 and cardiovascular disease", BMJ, 369, pp.m1997~ (2020)
44. "ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic" (2020)[URL]
45. Guo T, "Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019(COVID-19)", JAMA Cardiol, 5, pp.811~818 (2020)
46. "Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19" (2020)[URL]
47. "Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians" (2020)[URL]
48. "Emergency preparedness and response: HAN00432" (2020)[URL]
49. Belhadjer Z, "Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV2 pandemic", Circulation, 142, pp.429~436 (2020)
50. Dufort EM, "Multisystem inflammatory syndrome in children in New York State", N Engl J Med, 383, pp.347~358 (2020)
51. Feldstein LR, "Multisystem inflammatory syndrome in U.S. children and adolescents", N Engl J Med, 383, pp.334~346 (2020)
52. Menikou S, "Kawasaki disease : the role of immune complexes revisited", Front Immunol, 10, pp.1156~ (2019)
53. Elias MD, "Management of multisystem inflammatory syndrome in children associated with COVID-19 : a survey from the International Kawasaki Disease Registry", CJC Open, 2, pp.632~640 (2020)

관련 논문AI추천